Investor Relations

Investor Relations

BioSig Technologies, Inc Corporate Summary

September 2023

View Corporate Summary

Latest Annual Report

View Annual Report

Stock Information


Nasdaq: BSGM




52 week Low/High

Day Low/High

Company Overview

BioSig Technologies is a medical device company commercializing a proprietary technology platform designed to improve the $8 billion electrophysiology (EP) marketplace. By 2028, the EP market is expected to reach $16 billion, with an estimated 11.2% CAGR.

Investor Relations

T: (203) 409-5444 x 133

Transfer Agent

Securities Transfer Corporation
2901 N. Dallas Parkway
Suite 380
Plano, TX 75093
T: (469) 633-0101
F: (469) 633-0088